“It’s Never Too Early to Start.” Palliative Care Helps Improve Quality of Life
What is the role of palliative care in cancer treatment? Cancer.Net Associate Editor Kavitha Ramchandran, MD, gives insight on how this approach is used in cancer care.
What is the role of palliative care in cancer treatment? Cancer.Net Associate Editor Kavitha Ramchandran, MD, gives insight on how this approach is used in cancer care.
Second opinions can save lives, especially when it comes to cancer. Dr. Schapira covers the ins and outs of second (and third and fourth) opinions.
World Cancer Day is this week. In recognition of this day, Dr. Schapira describes 4 ways that patients can put themselves in the driver’s seat of their cancer care.
Once you have finished cancer treatment, it is impossible to reconstruct the exact life you had prior to diagnosis. Jennifer Titche talks about the challenges she faces as a young breast cancer survivor and how she is building a life with new goals.
Susan Cohn, MD, shares a personal story about the courage of parents who enrolled their child in a clinical trial for a drug that is now approved to treat neuroblastoma.
What is low dose CT screening for lung cancer? What are the benefits and risks? Should I ask my doctor about it? In this podcast, Dr. Bernardo Goulart answers these questions and more.
During or after a natural disaster or other emergency, you may be told to evacuate or “shelter in place.” What does this mean if you are being treated for cancer? And how can you be prepared?
In March 2013, John’s wife Lori found a lump in her breast. Lori, a radiation oncologist, soon went from giving cancer care to receiving it. In this guest post, John talks about how to navigate a cancer diagnosis, a journey for which we are all ill-prepared.
Although many women who have a mastectomy choose to have reconstructive surgery, wearing a breast prosthesis or breast form is another option. Breast cancer survivor Andrea Zinn talks about the process of choosing and being fitted for a breast prosthesis.
In January, Randy Hillard was part of the U.S. Food and Drug Administration committee that considered the first application for a “biosimilar” medication. In this guest post, he describes patients’ role in the drug approval process and how the committee’s decision could influence cancer care in the future.